Price Alert

Hologic Inc. (HOLX)

NASDAQ: HOLX · Real-Time Price · USD

68.37

0.46 (0.68%)

At close: Oct 03, 2025, 2:25 PM

0.68% (1D)

Bid	68.4
Market Cap	15.21B
Revenue (ttm)	4.04B
Net Income (ttm)	557.1M
EPS (ttm)	2.41
PE Ratio (ttm)	28.37
Forward PE	14.86
Analyst	Buy
Dividends	n/a

Ask	68.43
Volume	648,761
Avg. Volume (20D)	1,929,692
Open	67.92
Previous Close	67.91
Day's Range	67.55 - 69.23
52-Week Range	51.90 - 84.39
Beta	0.57
Ex-Dividend Date	n/a

About HOLX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol HOLX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for HOLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Hologic Inc. is scheduled to release its earnings on Nov 3, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+0.51%

HOLX stock has given up its prior gain. Hologic sh... Unlock content with Pro Subscription

2 months ago

+0.51%

Hologic shares are trading higher after Morgan Stanley and UBS raised their respective price targets on the stock.

News

Just now · zacks.com

HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests

Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.

1 day ago · zacks.com

Why Hologic (HOLX) Outpaced the Stock Market Today

In the closing of the recent trading day, Hologic (HOLX) stood at $67.91, denoting a +1.3% move from the preceding trading day.

1 day ago · businesswire.com

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025.

1 day ago · businesswire.com

Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #Bacterial--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Panther Fus...

1 day ago · zacks.com

HOLX vs. IDXX: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic (HOLX) and Idexx Laboratories (IDXX). But which of these two companies is the best option for those look...